$GOSS
Gossamer Bio, Inc.

2019 Q2 Form 10-Q Financial Statement

#000156459019018973 Filed on May 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.670M $8.030M $2.600M
YoY Change 109.76% 208.85%
% of Gross Profit
Research & Development $35.68M $24.98M $2.624M
YoY Change 349.89% 852.1%
% of Gross Profit
Depreciation & Amortization $200.0K $169.0K $6.000K
YoY Change 566.67% 2716.67%
% of Gross Profit
Operating Expenses $46.35M $34.02M $26.13M
YoY Change 40.3% 30.2%
Operating Profit -$46.35M -$34.02M -$26.13M
YoY Change 40.3% 30.2%
Interest Expense $19.00K $90.00K
YoY Change -78.89%
% of Operating Profit
Other Income/Expense, Net $1.851M $1.406M $89.00K
YoY Change 517.0% 1479.78%
Pretax Income -$44.50M -$32.61M -$26.04M
YoY Change 35.92% 25.23%
Income Tax
% Of Pretax Income
Net Earnings -$44.50M -$32.61M -$26.04M
YoY Change 35.96% 25.25%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$738.3K -$495.0K -$411.5K
COMMON SHARES
Basic Shares Outstanding 65.89M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $464.0M $481.2M
YoY Change 788.89%
Cash & Equivalents $148.5M $170.8M $79.18M
Short-Term Investments $315.5M $310.4M
Other Short-Term Assets $25.60M $16.60M
YoY Change 3100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $489.6M $497.8M
YoY Change 825.49%
LONG-TERM ASSETS
Property, Plant & Equipment $4.814M $4.110M
YoY Change 243.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.367M $2.129M
YoY Change 241.75%
Total Long-Term Assets $17.59M $18.16M
YoY Change 877.11%
TOTAL ASSETS
Total Short-Term Assets $489.6M $497.8M
Total Long-Term Assets $17.59M $18.16M
Total Assets $507.2M $515.9M
YoY Change 827.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.030M $4.548M
YoY Change 236.67%
Accrued Expenses $9.204M $7.879M
YoY Change 70.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $27.51M $25.15M
YoY Change 343.73%
LONG-TERM LIABILITIES
Long-Term Debt $28.28M $0.00
YoY Change
Other Long-Term Liabilities $9.900M $10.50M
YoY Change 1880.0%
Total Long-Term Liabilities $28.28M $10.50M
YoY Change 5556.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.51M $25.15M
Total Long-Term Liabilities $28.28M $10.50M
Total Liabilities $65.73M $35.69M
YoY Change 881.04%
SHAREHOLDERS EQUITY
Retained Earnings -$231.0M -$186.5M
YoY Change
Common Stock $671.9M $666.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $441.4M $480.3M -$29.42M
YoY Change
Total Liabilities & Shareholders Equity $507.2M $515.9M
YoY Change 827.19%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$44.50M -$32.61M -$26.04M
YoY Change 35.96% 25.25%
Depreciation, Depletion And Amortization $200.0K $169.0K $6.000K
YoY Change 566.67% 2716.67%
Cash From Operating Activities -$36.81M -$27.77M -$3.708M
YoY Change 441.32% 649.03%
INVESTING ACTIVITIES
Capital Expenditures -$1.380M $347.0K $511.0K
YoY Change 46.81% -32.09%
Acquisitions
YoY Change
Other Investing Activities -$12.50M -$197.8M $11.18M
YoY Change -69.24% -1869.23%
Cash From Investing Activities -$13.89M -$198.1M $10.67M
YoY Change -66.59% -1957.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $291.3M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.35M 291.3M 71.90M
YoY Change 1729.03% 305.18%
NET CHANGE
Cash From Operating Activities -36.81M -27.77M -3.708M
Cash From Investing Activities -13.89M -198.1M 10.67M
Cash From Financing Activities 28.35M 291.3M 71.90M
Net Change In Cash -22.35M 65.43M 78.86M
YoY Change -52.27% -17.03%
FREE CASH FLOW
Cash From Operating Activities -$36.81M -$27.77M -$3.708M
Capital Expenditures -$1.380M $347.0K $511.0K
Free Cash Flow -$35.43M -$28.12M -$4.219M
YoY Change 504.61% 566.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65893276
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170847000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105219000
CY2019Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
310374000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
123439000
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
200000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16567000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3095000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
497788000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
231953000
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4110000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3193000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11922000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2129000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4273000
CY2019Q1 us-gaap Assets
Assets
515949000
CY2018Q4 us-gaap Assets
Assets
239419000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4548000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2182000
CY2019Q1 goss Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
12725000
CY2018Q4 goss Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
10653000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10665000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
71904000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170847000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79176000
CY2019Q1 goss Noncash Investing And Financing Activities Change In Unrealized Gain On Marketable Securities Net Of Tax
NoncashInvestingAndFinancingActivitiesChangeInUnrealizedGainOnMarketableSecuritiesNetOfTax
140000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
739000
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
43000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8034000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
34017000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
26126000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-26126000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1406000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
89000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-26037000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20403000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10537000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7879000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7568000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
25152000
CY2018Q4 goss Accrued Liabilities Non Current
AccruedLiabilitiesNonCurrent
718000
CY2019Q1 us-gaap Liabilities
Liabilities
35689000
CY2018Q4 us-gaap Liabilities
Liabilities
21121000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
666648000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33853000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186474000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-153863000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
79000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-61000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
480260000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-120069000
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
515949000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239419000
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
49160177
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65891910
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15533450
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60029470
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8051418
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24983000
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2624000
CY2019Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1000000
CY2018Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
20898000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2604000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-34017000
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1049000
CY2018Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
89000
CY2019Q1 us-gaap Interest Expense
InterestExpense
19000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
376000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-32611000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
140000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
140000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32471000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26037000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.49
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36317230
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5797693
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
291344000
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
338367000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3089000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-6862000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-29420000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-32611000
CY2018Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2874000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
605000
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-26037000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
169000
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3089000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
605000
CY2019Q1 goss Increase Decrease In Operating Lease Right Of Use Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
-61000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3472000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
94000
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2144000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
425000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2132000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
546000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-789000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
441000
CY2019Q1 goss Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
2072000
CY2018Q1 goss Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
-126000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1569000
CY2018Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
593000
CY2018Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-115000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27774000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3708000
CY2019Q1 goss Payments For Proceeds From Research And Development Asset Acquisitions
PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
1000000
CY2018Q1 goss Payments For Proceeds From Research And Development Asset Acquisitions
PaymentsForProceedsFromResearchAndDevelopmentAssetAcquisitions
-11176000
CY2019Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
222295000
CY2019Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
25500000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
347000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
511000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-198142000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
291273000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000
CY2018Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
71944000
CY2018Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
40000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
291344000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
65428000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
78861000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105419000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
315000
CY2018Q1 goss Acquisition Of In Process Research And Development Through Issuance Of Stock
AcquisitionOfInProcessResearchAndDevelopmentThroughIssuanceOfStock
19284000
CY2018Q1 goss Issuance Of Convertible Preferred Stock To Convert Debt And Accrued Interest
IssuanceOfConvertiblePreferredStockToConvertDebtAndAccruedInterest
6124000
CY2019Q1 goss Recognition Of Operating Lease Right Of Use Asset
RecognitionOfOperatingLeaseRightOfUseAsset
12458000
CY2019Q1 goss Recognition Of Operating Lease Liabilities
RecognitionOfOperatingLeaseLiabilities
13182000
CY2019Q1 goss Noncash Financing And Investing Conversions Of Convertible Preferred Stock To Common Stock
NoncashFinancingAndInvestingConversionsOfConvertiblePreferredStockToCommonStock
338367000
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:10pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting period. The most significant estimates in the Company&#8217;s condensed consolidated financial statements relate to accrued research and development expenses, the valuation of preferred and common stock, the valuation of stock options and the valuation allowance of deferred tax assets resulting from net operating losses. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results could differ from those estimates. </p>
CY2019Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one for every 4.5 shares
CY2019Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.0022
goss Funds Raised Through Preferred Equity Financing Convertible Note Financings And Completed Initial Public Offering
FundsRaisedThroughPreferredEquityFinancingConvertibleNoteFinancingsAndCompletedInitialPublicOffering
601300000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4576000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3490000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
466000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
297000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2533000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4102000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2170000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1318000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2697000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1858000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
769000
CY2019Q1 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2019Q1 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2019Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
310243000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
153000
CY2019Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22000
CY2019Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
310374000
CY2019Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
261450000
CY2019Q1 goss Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
48924000
CY2019Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2019Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
5862450
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7482032
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5107329
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2390144
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
27500
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7469973
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
160682
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.51
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
21.74
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.61
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.08
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.20
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y7M6D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P8Y10M24D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16343000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
72708000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2968000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3089000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
605000
CY2019Q1 goss Non Cancelable Operating Sublease Expiration Date For Initial Lease Space
NonCancelableOperatingSubleaseExpirationDateForInitialLeaseSpace
2024-12
CY2019Q1 goss Non Cancelable Operating Sublease Expiration Date For Expansion Space Leased
NonCancelableOperatingSubleaseExpirationDateForExpansionSpaceLeased
2022-12
CY2019Q1 us-gaap Lessee Operating Sublease Existence Of Option To Extend
LesseeOperatingSubleaseExistenceOfOptionToExtend
true
CY2019Q1 goss Operating Sublease Annual Increase Percentage For Base Rent
OperatingSubleaseAnnualIncreasePercentageForBaseRent
0.03
CY2019Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.07
CY2019Q1 us-gaap Lessee Operating Sublease Option To Extend
LesseeOperatingSubleaseOptionToExtend
options to extend for the entire premises through October 2028
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
753000
CY2019Q1 us-gaap Variable Lease Cost
VariableLeaseCost
395000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
14000
CY2019Q1 us-gaap Lease Cost
LeaseCost
1162000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1200000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2216000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3035000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3123000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3216000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1690000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
1741000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15021000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2314000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
12707000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2944000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3035000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3123000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3216000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1690000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1741000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
15749000
CY2018Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000

Files In Submission

Name View Source Status
0001564590-19-018973-index-headers.html Edgar Link pending
0001564590-19-018973-index.html Edgar Link pending
0001564590-19-018973.txt Edgar Link pending
0001564590-19-018973-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
goss-10q_20190331.htm Edgar Link pending
goss-20190331.xml Edgar Link completed
goss-20190331.xsd Edgar Link pending
goss-20190331_cal.xml Edgar Link unprocessable
goss-20190331_def.xml Edgar Link unprocessable
goss-20190331_lab.xml Edgar Link unprocessable
goss-20190331_pre.xml Edgar Link unprocessable
goss-ex311_6.htm Edgar Link pending
goss-ex312_7.htm Edgar Link pending
goss-ex321_8.htm Edgar Link pending
goss-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending